Results 221 to 230 of about 734,643 (308)
ABSTRACT The SAPIEN M3 system has been recently approved for transcatheter mitral valve replacement (TMVR). The transeptal guide sheath is used to deploy the dock, which is completely released before inserting and deploying the M3 valve using the same femoral access, transeptal puncture (TSP) and guide sheath.
Clara Fernandez‐Cordon +5 more
wiley +1 more source
Recognizing the Shark Fin Pattern: An Ominous Electrocardiographic Diagnosis
Vaibhav Mishra, MD, DM Cardiology +3 more
doaj +1 more source
ABSTRACT Background Frailty is highly prevalent among elderly patients with coronary heart disease (CHD) undergoing percutaneous coronary intervention (PCI) and is associated with adverse clinical outcomes and impaired health‐related quality of life.
Meixun Huang +5 more
wiley +1 more source
The Relationship is the Intervention: Listening to Adults With Congenital Heart Disease. [PDF]
Agarwal A, Valente J, Alano L.
europepmc +1 more source
ABSTRACT Failure of true‐lumen re‐entry after subintimal wire passage is a well‐recognized limitation of endovascular treatment for external iliac artery (EIA) chronic total occlusions (CTO). We report a 73‐year‐old woman with severe limb ischemia and a prior failed endovascular attempt who underwent hybrid left common femoral artery (CFA ...
Bibhas Amatya, Dipankar Mukherjee
wiley +1 more source
Correction: Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry. [PDF]
Yildirim M +6 more
europepmc +1 more source
ABSTRACT Background Cangrelor reduces thrombotic events in patients undergoing percutaneous coronary intervention (PCI), with the advantage of rapid onset and offset. However, premature discontinuation may increase the risk of acute thrombosis for patients undergoing complex/high‐risk PCI (CHIP).
Siyu Ma +8 more
wiley +1 more source
ABSTRACT Background Real‐world data after percutaneous coronary intervention (PCI) using drug‐coated balloons (DCBs) in acute coronary syndrome (ACS) are limited. Aims We compared 1‐year clinical outcomes after PCI with paclitaxel DCBs between the ACS and non‐ACS patients.
Takashi Muramatsu +18 more
wiley +1 more source
Publisher Correction: Clinical performance of the next generation Elecsys Troponin T high-sensitivity Gen 6 assay in acute coronary syndrome (PERFORM-TSIX): study design. [PDF]
Daniels LB +26 more
europepmc +1 more source

